Ercil Hakan, Arslan Burak, Ortoglu Ferhat, Alma Ergun, Unal Umut, Deniz Mehmet Eflatun, Senturk Aykut Bugra, Gurbuz Zafer Gokhan
Department of Urology, Ministry of Health, Adana Numune Training and Research Hospital, Serinevler Mh EgeBagatur Bul Adana Numune Egitim Arastirma Hastanesi, 01240, Yuregir, Adana, Turkey.
Department of Urology, Ministry of Health, Istanbul Taksim Training and Research Hospital, Istanbul, Turkey.
Int Urol Nephrol. 2017 Aug;49(8):1347-1352. doi: 10.1007/s11255-017-1619-6. Epub 2017 May 17.
To determine the parameters that may help the clinicians decide the best suitable treatment method for the pregnant women with symptomatic hydronephrosis which will be based on the easily accessible laboratory tests, monitoring methods and clinical symptoms.
Digital data and documents of 246 pregnant women with symptomatic hydronephrosis who were hospitalized in our clinic between the dates of January 2011 and January 2016 were retrospectively evaluated. All patients were statistically evaluated in terms of age, symptomatic maximal anterior-posterior diameter of the renal pelvis (MADP), parity, C-reactive protein (CRP) level, white blood cell count (WBC), presence of pyuria, growth of urine culture, fever, serum urine and creatinine levels, visual analog scale (VAS) score of pre- and post-therapy and threatened preterm labor.
The study includes a total of 211 pregnant women with symptomatic hydronephrosis. In the second and third trimester groups, the surgical treatment group statistically provided higher levels of CRP, WBC and VAS. Mean MADP in the second trimester of the conservative and surgical groups where symptomatic hydronephrosis was on the right side was 16.67 ± 4.67 and 28.68 ± 7.70 mm, respectively. Mean MADP in the third trimester group of the conservative and surgical groups where symptomatic hydronephrosis was on the right side was 16.96 ± 5.96 and 28.85 ± 7.64 mm, respectively.
In patients with symptomatic pregnancy hydronephrosis, the likelihood of surgical treatment for CRP levels, WBC counts and VAS is high.
确定基于易于获取的实验室检查、监测方法和临床症状，可帮助临床医生为有症状的肾盂积水孕妇决定最合适治疗方法的参数。
回顾性评估2011年1月至2016年1月期间在我院住院的246例有症状的肾盂积水孕妇的数字数据和文件。所有患者均在年龄、肾盂最大前后径（MADP）、产次、C反应蛋白（CRP）水平、白细胞计数（WBC）、脓尿的存在、尿培养生长情况、发热、血清尿素和肌酐水平、治疗前后视觉模拟量表（VAS）评分以及先兆早产方面进行了统计学评估。
该研究共纳入211例有症状的肾盂积水孕妇。在孕中期和孕晚期组中，手术治疗组的CRP、WBC和VAS水平在统计学上较高。右侧有症状的肾盂积水的保守治疗组和手术治疗组孕中期的平均MADP分别为16.67±4.67和28.68±7.70mm。右侧有症状的肾盂积水的保守治疗组和手术治疗组孕晚期的平均MADP分别为16.96±5.96和28.85±7.64mm。
在有症状的妊娠肾盂积水患者中，CRP水平、WBC计数和VAS评分高的患者接受手术治疗的可能性大。
